Literature DB >> 7270152

Sandhoff disease.

M Tatematsu, K Imaida, N Ito, H Togari, Y Suzuki, T Ogiu.   

Abstract

An autopsy case of Sandhoff disease in a 2-year-old boy is reported. Diagnosis was established by enzyme assay, which demonstrated total deficiency of hexosaminidase in the serum. Histochemical examination, using hematoxylin-eosin (H & E) and Luxol fast blue (LFB) stain, showed accumulation of LFB-positive material not only in cells of the cerebrum, cerebellum, spinal cord, and peripheral nervous system, but also in reticuloendothelial cells of the lymph nodes, spleen, thymus, and liver, in podocytes of renal glomeruli, in all types of renal tubular cells, in endothelial cells of small vessels, in fibroblasts, and in epithelial cells of the epididymis and ductus deferens. Electron microscopic examination showed that these deposits contained electrondense membranous bodies. Lipid analysis demonstrated a marked elevation of ganglioside GM2 and its asialo derivative in the brain and liver. Accumulation of globoside was found in the liver, kidney, and spleen. There was complete absence of hexosaminidase in the brain and liver.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7270152     DOI: 10.1111/j.1440-1827.1981.tb01391.x

Source DB:  PubMed          Journal:  Acta Pathol Jpn        ISSN: 0001-6632


  9 in total

Review 1.  Lipid biology of the podocyte--new perspectives offer new opportunities.

Authors:  Alessia Fornoni; Sandra Merscher; Jeffrey B Kopp
Journal:  Nat Rev Nephrol       Date:  2014-05-27       Impact factor: 28.314

2.  Ultrastructural pathology of dermal axons and Schwann cells in lysosomal diseases.

Authors:  S Walter; H H Goebel
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

3.  Lysosomal storage of oligosaccharide and glycosphingolipid in imino sugar treated cells.

Authors:  Stephanie D Boomkamp; J S Shane Rountree; David C A Neville; Raymond A Dwek; George W J Fleet; Terry D Butters
Journal:  Glycoconj J       Date:  2010-02-26       Impact factor: 2.916

4.  Thymic alterations in GM2 gangliosidoses model mice.

Authors:  Seiichi Kanzaki; Akira Yamaguchi; Kayoko Yamaguchi; Yoshitsugu Kojima; Kyoko Suzuki; Noriko Koumitsu; Yoji Nagashima; Kiyotaka Nagahama; Michiko Ehara; Yoshio Hirayasu; Akihide Ryo; Ichiro Aoki; Shoji Yamanaka
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

5.  Possible role of autoantibodies in the pathophysiology of GM2 gangliosidoses.

Authors:  Akira Yamaguchi; Kayoko Katsuyama; Kiyotaka Nagahama; Toshiyuki Takai; Ichiro Aoki; Shoji Yamanaka
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

Review 6.  Podocyte pathology and nephropathy - sphingolipids in glomerular diseases.

Authors:  Sandra Merscher; Alessia Fornoni
Journal:  Front Endocrinol (Lausanne)       Date:  2014-07-30       Impact factor: 5.555

Review 7.  Gangliosides in Podocyte Biology and Disease.

Authors:  Berkan Savas; Giuseppe Astarita; Massimo Aureli; Dil Sahali; Mario Ollero
Journal:  Int J Mol Sci       Date:  2020-12-17       Impact factor: 5.923

Review 8.  Lysosome function in glomerular health and disease.

Authors:  Catherine Meyer-Schwesinger
Journal:  Cell Tissue Res       Date:  2021-01-12       Impact factor: 4.051

9.  APOL1 polymorphism modulates sphingolipid profile of human podocytes.

Authors:  Manuela Valsecchi; Valentina Cazzetta; Ferdinando Oriolo; Xiqian Lan; Rocco Piazza; Moin A Saleem; Pravin C Singhal; Domenico Mavilio; Joanna Mikulak; Massimo Aureli
Journal:  Glycoconj J       Date:  2020-09-11       Impact factor: 2.916

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.